195 related articles for article (PubMed ID: 18622640)
1. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.
Bharucha AE; Low PA; Camilleri M; Burton D; Gehrking TL; Zinsmeister AR
Clin Auton Res; 2008 Aug; 18(4):194-202. PubMed ID: 18622640
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
Bharucha AE; Low P; Camilleri M; Veil E; Burton D; Kudva Y; Shah P; Gehrking T; Zinsmeister AR
Gut; 2013 May; 62(5):708-15. PubMed ID: 22677718
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine.
O'Dea CJ; Brookes JH; Wattchow DA
Colorectal Dis; 2010 Jun; 12(6):540-8. PubMed ID: 19508545
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation.
Mouchli MA; Camilleri M; Lee T; Parthasarathy G; Vijayvargiya P; Halland M; Acosta A; Bharucha AE
Neurogastroenterol Motil; 2016 Jun; 28(6):871-8. PubMed ID: 26840188
[TBL] [Abstract][Full Text] [Related]
5. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.
Manini ML; Camilleri M; Grothe R; Di Lorenzo C
Paediatr Drugs; 2018 Apr; 20(2):173-180. PubMed ID: 29243034
[TBL] [Abstract][Full Text] [Related]
6. [Stopping smoking and constipation].
Lagrue G; Cormier S; Mautrait C; Diviné C
Presse Med; 2006 Feb; 35(2 Pt 1):246-8. PubMed ID: 16493356
[TBL] [Abstract][Full Text] [Related]
7. Slow-transit constipation: solitary symptom of a systemic gastrointestinal disease.
Altomare DF; Portincasa P; Rinaldi M; Di Ciaula A; Martinelli E; Amoruso A; Palasciano G; Memeo V
Dis Colon Rectum; 1999 Feb; 42(2):231-40. PubMed ID: 10211501
[TBL] [Abstract][Full Text] [Related]
8. Pyridostigmine in the treatment of orthostatic intolerance.
Gales BJ; Gales MA
Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
[TBL] [Abstract][Full Text] [Related]
9. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
[TBL] [Abstract][Full Text] [Related]
10. Colonic transit time in diabetic patients--comparison with healthy subjects and the effect of autonomic neuropathy.
Jung HK; Kim DY; Moon IH; Hong YS
Yonsei Med J; 2003 Apr; 44(2):265-72. PubMed ID: 12728467
[TBL] [Abstract][Full Text] [Related]
11. Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug?
Yamamoto T; Sakakibara R; Yamanaka Y; Uchiyama T; Asahina M; Liu Z; Ito T; Koyama Y; Awa Y; Yamamoto K; Kinou M; Hattori T
Clin Auton Res; 2006 Aug; 16(4):296-8. PubMed ID: 16862395
[TBL] [Abstract][Full Text] [Related]
12. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
13. The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.
Robinson-Papp J; Nmashie A; Pedowitz E; George MC; Sharma S; Murray J; Benn EKT; Lawrence SA; Machac J; Heiba S; Kim-Schulze S; Navis A; Roland BC; Morgello S
J Neurovirol; 2019 Aug; 25(4):551-559. PubMed ID: 31098925
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
[TBL] [Abstract][Full Text] [Related]
16. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
Sandroni P; Opfer-Gehrking TL; Singer W; Low PA
Clin Auton Res; 2005 Feb; 15(1):51-3. PubMed ID: 15768203
[TBL] [Abstract][Full Text] [Related]
17. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection.
Schang JC; Devroede G; Pilote M
Dis Colon Rectum; 1993 Apr; 36(4):330-6. PubMed ID: 8458257
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans.
Coulie B; Szarka LA; Camilleri M; Burton DD; McKinzie S; Stambler N; Cedarbaum JM
Gastroenterology; 2000 Jul; 119(1):41-50. PubMed ID: 10889153
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variation of colonic motor functions in chronic constipation.
Ravi K; Bharucha AE; Camilleri M; Rhoten D; Bakken T; Zinsmeister AR
Gastroenterology; 2010 Jan; 138(1):89-97. PubMed ID: 19660461
[TBL] [Abstract][Full Text] [Related]
20. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
